Kotra Industries

KOTRA

MYQ0002OO004

Pharmaceuticals

End-of-day quote BURSA MALAYSIA Other stock markets 03:30:00 13/06/2024 am IST			5-day change	1st Jan Change
4.33 ^MYR	+1.17%		-0.92%	-10.35%

20/05	Kotra Industries Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
21/02	Kotra Industries Berhad Announces Single Tier Interim Dividend for the Financial Year Ending 30 June 2024, Payable on 21 March 2024	CI

Kotra Industries Berhad Appoints Piong Chee Kien as Non Independent and Non Executive Director

February 19, 2019

Kotra Industries Berhad appointed Piong Chee Kien as Non Independent and Non Executive Director, effective from February 19, 2019. Currently, he is General Manager of Lonnix (M) Sdn Bhd.

Latest news about Kotra Industries

Kotra Industries Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	20/05	CI
Kotra Industries Berhad Announces Single Tier Interim Dividend for the Financial Year Ending 30 June 2024, Payable on 21 March 2024	21/02	CI
Kotra Industries Berhad Reports Written Off Results for the Second Quarter Ended December 31, 2023	21/02	CI
Kotra Industries Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	21/02	CI
Kotra Industries Posts Lower Profit, Revenue in Fiscal Q1	29/11	MT
Kotra Industries Berhad Reports Earnings Results for the First Quarter Ended September 30, 2023	28/11	CI
Kotra Industries to Seek Shareholders' Nod to Renew Transactions Authority	06/23/06	MT
Kotra Industries to Pay Dividend Despite Profit Drop in Fiscal Q4	24/23/24	MT
Kotra Industries Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2023	23/23/23	CI
Kotra Industries Berhad Announces Second Interim Dividend for the Financial Year Ended 30 June 2023, Payable on 12 October 2023	23/23/23	CI
Kotra Industries Profit Edges Up in Fiscal Q3	29/23/29	MT
Kotra Industries Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	26/23/26	CI
Kotra Industries Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	24/23/24	CI
Kotra Industries Berhad Announces Single Tier Interim Dividend for the Financial Year Ending 30 June 2023, Payable 23 March 2023	24/23/24	CI
Kotra Industries Berhad Reports Earnings Results for the First Quarter Ended September 30, 2022	29/22/29	CI
Kotra Industries Berhad Announces Single Tier Final Dividend for the Financial Year Ended 30 June 2022, Payable on 08 December 2022	06/22/06	CI
Kotra Industries Berhad Reports Earnings Results for the Full Year Ended June 30, 2022	29/22/29	CI
Kotra Industries Berhad Reports Earnings Results for the Fourth Quarter Ended June 30, 2022	29/22/29	CI
Kotra Industries Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	30/22/30	CI
Kotra Industries Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	24/22/24	CI
The Board of Directors of Kotra Industries Berhad Declares an Interim Single Tier Dividend in Respect of the Financial Year Ending June 30, 2022, Payable on March 24, 2022	24/22/24	CI
Kotra Industries Berhad Reports Earnings Results for the First Quarter Ended September 30, 2021	26/21/26	CI
Kotra Industries Berhad Declares Final Dividend for the Financial Year Ended 30 June 2021, Payable on 09 Dec. 2021	06/21/06	CI
Kotra Industries Berhad : Books Higher Profit, Revenue in Fiscal Q4 as Sales Volume Grows	03/21/03	MT
Kotra Industries Berhad Reports Earnings Results for the Fourth Quarter Ended June 30, 2021	30/21/30	CI

Kotra Industries Berhad is a Malaysia-based company, which is engaged in investment holding and the provision of management. The Company, through its subsidiary, Kotra Pharma (M) Sdn. Bhd., is engaged in developing, manufacturing and supplying of pharmaceutical and healthcare products. The Company offers a range of healthcare products of over-the-counter (OTC) supplements, nutritional products as well as pharmaceutical products in various dosage forms. The Company's brands include Appeton, Axcel, Vaxcel and Arite. The Appeton brand offers OTC products that cater to all stages of life, from prenatal development needs to geriatric health supplements. The Axcel brand specializes in pediatric care, anti-infective medicine and dermatological care. The Vaxcel branded products are focused on sterile injectables that feature a range of antibiotics to treat a range of health conditions. The Company's metered dose inhalers are branded as Arite.

Sector

Pharmaceuticals

Calendar

21/08/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Kotra Industries

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

4.33 MYR

Average target price

4.817 MYR

Spread / Average Target

+11.24%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
KOTRA INDUSTRIES	-10.35%	14Cr
ELI LILLY AND COMPANY	+51.54%	80TCr
JOHNSON & JOHNSON	-7.20%	35TCr
MERCK & CO., INC.	+18.67%	33TCr
ABBVIE INC.	+7.48%	29TCr
ASTRAZENECA PLC	+16.91%	25TCr
ROCHE HOLDING AG	+0.53%	22TCr
NOVARTIS AG	+11.06%	22TCr
AMGEN INC.	+3.64%	16TCr
PFIZER, INC.	-3.96%	16TCr

Other Pharmaceuticals